Inhibitory action of islet amyloid polypeptide and calcitonin gene-related peptide on release of insulin from the isolated perfused rat pancreas

M. Kogire, J. Ishizuka, J. C. Thompson, G. H. Greeley

Research output: Contribution to journalArticle

58 Citations (Scopus)

Abstract

Islet (or insulinoma) amyloid polypeptide (IAPP) is a 37-residue peptide recently purified from amyloid deposits in the pancreas of patients with type 2 diabetes and from amyloid deposits of a human insulinoma. IAPP immunoreactivity has been identified in islet B cells of diabetic and nondiabetic humans. IAPP is structurally similar to calcitonin gene-related peptide (CGRP). The purpose of this study was to examine the effects of IAPP and CGRP on glucose- and carbachol-stimulated release of insulin and pancreatic polypeptide (PP) from the isolated perfused rat pancreas. IAPP and CGRP, at 10-7 M, failed to inhibit glucose-stimulated (16.7 mM) release of insulin. At the same concentration, however, IAPP significantly (p < 0.05) inhibited carbachol-stimulated (10-7 M) release of insulin by 30%, and CGRP significantly inhibited carbachol-stimulated release of insulin by 33% when compared with the control group. IAPP also significantly decreased carbachol-stimulated release of PP. IAPP and CGRP, at 10-8 M, did not inhibit carbachol-stimulated release of insulin and PP. These results suggest that IAPP and CGRP may have roles in the regulation of secretion of insulin. IAPP may inhibit secretion of insulin, at least in part, by blocking cholinergic mechanisms.

Original languageEnglish (US)
Pages (from-to)459-463
Number of pages5
JournalPancreas
Volume6
Issue number4
StatePublished - 1991

Fingerprint

Islet Amyloid Polypeptide
Calcitonin Gene-Related Peptide
Pancreas
Insulin
Carbachol
Pancreatic Polypeptide
Amyloid Plaques
Glucose
Insulinoma
Islets of Langerhans
Type 2 Diabetes Mellitus
Cholinergic Agents
B-Lymphocytes

Keywords

  • Calcitonin gene-related peptide
  • Carbachol
  • Glucose
  • Islet amyloid polypeptide
  • Isolated perfused rat pancreas
  • Release of insulin

ASJC Scopus subject areas

  • Endocrinology
  • Gastroenterology

Cite this

Inhibitory action of islet amyloid polypeptide and calcitonin gene-related peptide on release of insulin from the isolated perfused rat pancreas. / Kogire, M.; Ishizuka, J.; Thompson, J. C.; Greeley, G. H.

In: Pancreas, Vol. 6, No. 4, 1991, p. 459-463.

Research output: Contribution to journalArticle

Kogire, M. ; Ishizuka, J. ; Thompson, J. C. ; Greeley, G. H. / Inhibitory action of islet amyloid polypeptide and calcitonin gene-related peptide on release of insulin from the isolated perfused rat pancreas. In: Pancreas. 1991 ; Vol. 6, No. 4. pp. 459-463.
@article{c9e92810e4b64d9285e4e42dc80e390b,
title = "Inhibitory action of islet amyloid polypeptide and calcitonin gene-related peptide on release of insulin from the isolated perfused rat pancreas",
abstract = "Islet (or insulinoma) amyloid polypeptide (IAPP) is a 37-residue peptide recently purified from amyloid deposits in the pancreas of patients with type 2 diabetes and from amyloid deposits of a human insulinoma. IAPP immunoreactivity has been identified in islet B cells of diabetic and nondiabetic humans. IAPP is structurally similar to calcitonin gene-related peptide (CGRP). The purpose of this study was to examine the effects of IAPP and CGRP on glucose- and carbachol-stimulated release of insulin and pancreatic polypeptide (PP) from the isolated perfused rat pancreas. IAPP and CGRP, at 10-7 M, failed to inhibit glucose-stimulated (16.7 mM) release of insulin. At the same concentration, however, IAPP significantly (p < 0.05) inhibited carbachol-stimulated (10-7 M) release of insulin by 30{\%}, and CGRP significantly inhibited carbachol-stimulated release of insulin by 33{\%} when compared with the control group. IAPP also significantly decreased carbachol-stimulated release of PP. IAPP and CGRP, at 10-8 M, did not inhibit carbachol-stimulated release of insulin and PP. These results suggest that IAPP and CGRP may have roles in the regulation of secretion of insulin. IAPP may inhibit secretion of insulin, at least in part, by blocking cholinergic mechanisms.",
keywords = "Calcitonin gene-related peptide, Carbachol, Glucose, Islet amyloid polypeptide, Isolated perfused rat pancreas, Release of insulin",
author = "M. Kogire and J. Ishizuka and Thompson, {J. C.} and Greeley, {G. H.}",
year = "1991",
language = "English (US)",
volume = "6",
pages = "459--463",
journal = "Pancreas",
issn = "0885-3177",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Inhibitory action of islet amyloid polypeptide and calcitonin gene-related peptide on release of insulin from the isolated perfused rat pancreas

AU - Kogire, M.

AU - Ishizuka, J.

AU - Thompson, J. C.

AU - Greeley, G. H.

PY - 1991

Y1 - 1991

N2 - Islet (or insulinoma) amyloid polypeptide (IAPP) is a 37-residue peptide recently purified from amyloid deposits in the pancreas of patients with type 2 diabetes and from amyloid deposits of a human insulinoma. IAPP immunoreactivity has been identified in islet B cells of diabetic and nondiabetic humans. IAPP is structurally similar to calcitonin gene-related peptide (CGRP). The purpose of this study was to examine the effects of IAPP and CGRP on glucose- and carbachol-stimulated release of insulin and pancreatic polypeptide (PP) from the isolated perfused rat pancreas. IAPP and CGRP, at 10-7 M, failed to inhibit glucose-stimulated (16.7 mM) release of insulin. At the same concentration, however, IAPP significantly (p < 0.05) inhibited carbachol-stimulated (10-7 M) release of insulin by 30%, and CGRP significantly inhibited carbachol-stimulated release of insulin by 33% when compared with the control group. IAPP also significantly decreased carbachol-stimulated release of PP. IAPP and CGRP, at 10-8 M, did not inhibit carbachol-stimulated release of insulin and PP. These results suggest that IAPP and CGRP may have roles in the regulation of secretion of insulin. IAPP may inhibit secretion of insulin, at least in part, by blocking cholinergic mechanisms.

AB - Islet (or insulinoma) amyloid polypeptide (IAPP) is a 37-residue peptide recently purified from amyloid deposits in the pancreas of patients with type 2 diabetes and from amyloid deposits of a human insulinoma. IAPP immunoreactivity has been identified in islet B cells of diabetic and nondiabetic humans. IAPP is structurally similar to calcitonin gene-related peptide (CGRP). The purpose of this study was to examine the effects of IAPP and CGRP on glucose- and carbachol-stimulated release of insulin and pancreatic polypeptide (PP) from the isolated perfused rat pancreas. IAPP and CGRP, at 10-7 M, failed to inhibit glucose-stimulated (16.7 mM) release of insulin. At the same concentration, however, IAPP significantly (p < 0.05) inhibited carbachol-stimulated (10-7 M) release of insulin by 30%, and CGRP significantly inhibited carbachol-stimulated release of insulin by 33% when compared with the control group. IAPP also significantly decreased carbachol-stimulated release of PP. IAPP and CGRP, at 10-8 M, did not inhibit carbachol-stimulated release of insulin and PP. These results suggest that IAPP and CGRP may have roles in the regulation of secretion of insulin. IAPP may inhibit secretion of insulin, at least in part, by blocking cholinergic mechanisms.

KW - Calcitonin gene-related peptide

KW - Carbachol

KW - Glucose

KW - Islet amyloid polypeptide

KW - Isolated perfused rat pancreas

KW - Release of insulin

UR - http://www.scopus.com/inward/record.url?scp=0025764548&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025764548&partnerID=8YFLogxK

M3 - Article

C2 - 1876601

AN - SCOPUS:0025764548

VL - 6

SP - 459

EP - 463

JO - Pancreas

JF - Pancreas

SN - 0885-3177

IS - 4

ER -